| Hippo pathway effector Yap promotes cardiac regeneration M Xin, Y Kim, LB Sutherland, M Murakami, X Qi, J McAnally, ER Porrello, ... Proceedings of the National Academy of Sciences 110 (34), 13839-13844, 2013 | 911 | 2013 |
| Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size M Xin, Y Kim, LB Sutherland, X Qi, J McAnally, RJ Schwartz, ... Science signaling 4 (196), ra70-ra70, 2011 | 557 | 2011 |
| An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 N Liu, AH Williams, Y Kim, J McAnally, S Bezprozvannaya, LB Sutherland, ... Proceedings of the National Academy of Sciences 104 (52), 20844-20849, 2007 | 525 | 2007 |
| MEF2C transcription factor controls chondrocyte hypertrophy and bone development MA Arnold, Y Kim, MP Czubryt, D Phan, J McAnally, X Qi, JM Shelton, ... Developmental cell 12 (3), 377-389, 2007 | 498 | 2007 |
| The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice Y Kim, D Phan, E Van Rooij, DZ Wang, J McAnally, X Qi, JA Richardson, ... The Journal of clinical investigation 118 (1), 124-132, 2008 | 289 | 2008 |
| Genetic variants associated with cancer therapy–induced cardiomyopathy P Garcia-Pavia, Y Kim, MA Restrepo-Cordoba, IG Lunde, H Wakimoto, ... Circulation 140 (1), 31-41, 2019 | 253 | 2019 |
| Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle Differentiation M Haberland, MA Arnold, J McAnally, D Phan, Y Kim, EN Olson Molecular and cellular biology 27 (2), 518-525, 2007 | 192 | 2007 |
| Myocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain development MH Mokalled, A Johnson, Y Kim, J Oh, EN Olson Development 137 (14), 2365-2374, 2010 | 141 | 2010 |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies D Reichart, EL Lindberg, H Maatz, AMA Miranda, A Viveiros, N Shvetsov, ... Science 377 (6606), eabo1984, 2022 | 105 | 2022 |
| GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm A Sharma, LK Wasson, JAL Willcox, SU Morton, JM Gorham, ... Elife 9, e53278, 2020 | 42 | 2020 |
| Mechanisms of congenital heart disease caused by NAA15 haploinsufficiency T Ward, W Tai, S Morton, F Impens, P Van Damme, D Van Haver, ... Circulation research 128 (8), 1156-1169, 2021 | 31 | 2021 |
| Discordant clinical features of identical hypertrophic cardiomyopathy twins GG Repetti, Y Kim, AC Pereira, J Ingles, MW Russell, NK Lakdawala, ... Proceedings of the National Academy of Sciences 118 (10), e2021717118, 2021 | 30 | 2021 |
| Genetics of cancer therapy-associated cardiotoxicity Y Kim, JG Seidman, CE Seidman Journal of Molecular and Cellular Cardiology 167, 85-91, 2022 | 13 | 2022 |
| Transforming Growth Factor-β Analysis of the VANISH Trial Cohort Y Kim, M Mastali, JE Van Eyk, EJ Orav, CR Vissing, SM Day, ... Circulation: Heart Failure 16 (4), e010314, 2023 | 1 | 2023 |
| Genetic Contribution to End-Stage Cardiomyopathy Requiring Heart Transplantation Y Kim, OB Gunnarsdóttir, A Viveiros, D Reichart, D Quiat, JAL Willcox, ... Circulation: Genomic and Precision Medicine 16 (5), 452-461, 2023 | | 2023 |
| Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet? JR Wong-Siegel, Y Kim, NO Stitziel, A Javaheri Cardio Oncology, 2023 | | 2023 |
| Myocarditis and Inflammatory Cardiomyopathy Y Kim, DM Dudzinski MGH Cardiology Board Review, 551-563, 2021 | | 2021 |
